Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-057515
Date:2021-09-22
Issuer: PMV PHARMACEUTICALS, INC. (PMVP)
Original Submission Date:

Reporting Person:

LEVINE ARNOLD J
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3 CRANBURY, NJ 08512

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-22 S 3,500 d $30.00 409,842 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 27, 2021.

Elevate your investments